Join Steven Chamow, Senior Vice President, CMC, Alira Health, at Bioprocess International US West on March 29-31, 2021. Connect with Steve to discuss how Alira Health can help to facilitate the…
Forbes has named Alira Health one of America’s Best Management Consulting Firms in the healthcare and life sciences space. Chamow & Associates is proud to be a part of the Alira…
In this piece, Nicolas Gaspar, Ph.D., Senior Consultant, Bioassay Development and Quality Control, offers insights for working with a CDMO by digging into the importance of potency as a quality…
A key structural feature of antibody therapeutics is their ability to both bind to antigen and to recruit effector functions of the immune system such as antibody dependent cell mediated…
In this Digital Brief recording, Alira Health’s Steven Chamow, Ph.D., Senior Vice President, CMC Development, leads an interactive briefing on the impact of COVID-19 on clinical biomanufacturing and supply chains.…
Chamow & Associates is pleased to announce that BioProcess International has awarded our article, “Capture of CH1-Containing Bispecific Antibodies: Evaluating an Alternative to Protein A,” by Steven M. Chamow, Angela Linderholm, Katherine…
Join us for a 30-minute fast-track digital brief on the Impact of COVID-19 on Clinical Biomanufacturing and Supply Chains. About this Event Since the onset of the COVID-19 pandemic, scientists…
Chamow and Associates’ expertise in biopharmaceutical product development expands Alira Health’s lifecycle of healthcare advisory services. FRAMINGHAM, Mass. – January 7, 2021 – Alira Health (www.alirahealth.com), a leading international healthcare…
Chamow & Associates is pleased to announce a new Webinars page on our website. This page is now available under the “Insights” section. Here our visitors will find the following:…
Chamow & Associates hosted a free webinar titled “CDMO Selection for Bispecific Antibody Development: A Case Study Matching Capability to Need” on December 1, 2020. The webinar addressed the CDMO selection…